Days Inventory is also known as Days Sales of Inventory (DSI). Biogen's Average Total Inventories for the
three
months ended in Dec. 2022 was R$7,131 Mil. Biogen's Cost of Goods Sold for the
three
months ended in Dec. 2022 was R$2,995 Mil.
Hence, Biogen's Days Inventory for the
three
months ended in Dec. 2022 was 217.29.
The historical rank and industry rank for Biogen's Days Inventory or its related term are showing as below:
BSP:BIIB34'
s Days Inventory Range Over the Past 10 Years
Min: 161.85 Med: 214.58 Max: 249.74
Current: 210.85
During the past 13 years, Biogen's highest Days Inventory was 249.74. The lowest was 161.85. And the median was 214.58.
BSP:BIIB34's Days Inventory is ranked worse than 70.27% of 999
companies
in the Drug Manufacturers industry
Industry Median: 148.40
vs BSP:BIIB34: 210.85
Biogen's Days Inventory
increased
from Dec. 2021 (180.39) to Dec. 2022 (217.29).
It might indicate that Biogen's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Biogen's Inventory Turnover for the
three
months ended in Dec. 2022 was 0.42.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Biogen's Inventory-to-Revenue for the
three
months ended in Dec. 2022 was 0.53.
Biogen Days Inventory Historical Data
The historical data trend for Biogen's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Biogen Annual Data
Trend
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Days Inventory
170.39
157.17
172.90
201.01
224.40
Biogen Quarterly Data
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Days Inventory
180.39
166.50
234.95
254.69
217.29
Competitive Comparison
For the Drug Manufacturers - General subindustry, Biogen's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biogen Days Inventory Distribution
For the Drug Manufacturers industry and Healthcare sector, Biogen's Days Inventory distribution charts can be found below:
* The bar in red indicates where Biogen's Days Inventory falls in comparison to its industry or sector. The grey bar indicates the Days Inventory's extreme value range as defined by GuruFocus.
Biogen Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Biogen's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biogen (BSP:BIIB34) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Biogen's Inventory Turnover for the
three
months ended in Dec. 2022 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Biogen's Inventory to Revenue for the
three
months ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Biogen Days Inventory Related Terms
Thank you for viewing the detailed overview of Biogen's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021, followed by Leqembi in January 2023.
Create New Portfolio
Portfolio Contest
Personalize
Premium Gurus 
(1.39%) Volume: 6 Mar. 22
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
BSP:BIIB34 has been successfully added to your 
